The increase in the prevalence of obesity represents a worldwide phenomenon in all age
groups and is pathologically and genetically correlated with several metabolic and …

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide, and
a major cause of liver cirrhosis and hepatocellular carcinoma. NAFLD is intimately linked …

Background In addition to decreasing the level of cholesterol, proprotein convertase subtilis
kexin 9 (PCSK9) inhibitor has pleiotropic effects, including immune regulation. However, the …

Metabolic syndrome (MetS) represents a cluster of metabolic and cardiovascular
complications, including obesity and visceral adiposity, insulin resistance, dyslipidemia …

The discovery of the NLRP 3 (NLR family, pyrin domain containing 3) inflammasome
provided an important molecular mechanism in the induction of the central pro‐inflammatory …

The risk of cardiovascular disease is increased in patients with rheumatoid arthritis
compared with the general population owing to the influence of traditional and non …

Background Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by
increased mortality associated with cardiometabolic disorders including dyslipidaemia …

Background Diagnosing seronegative rheumatoid arthritis (RA) can be challenging due to
complex diagnostic criteria. We sought to discover diagnostic biomarkers for seronegative …

Cardiovascular disease (CV) is the most common cause of premature mortality in patients
with rheumatoid arthritis (RA). This is the result of an accelerated atherosclerotic process …

While cardiovascular disease (CVD) is one of the major co-morbidities in patients with
rheumatoid arthritis (RA), the mechanism (s) that contribute to CVD in patients with RA …